Fulcrum Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Fulcrum Therapeutics Inc
TickerFULC
CIK #0001680581
CUSIP359616109
SectorLife Sciences - Pharmaceutical Preparations
Address26 Landsdowne Street, Cambridge, MA 02139
Source [EDGAR]
CIK Filing 2011 - 2025
[0001680581] 10-K
[0001680581] 10-Q
[0001680581] 3
[0001680581] 4
[0001680581] 5
[0001680581] 8-K
[0001680581] D
[0001680581] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Adage Capital Management LP Fulcrum Therapeutics Inc [2025-02-12] 0.0
Suvretta Capital Management LLC Fulcrum Therapeutics Inc [2025-01-06] 0.0
BlackRock Inc Fulcrum Therapeutics Inc [2024-12-06] 10.3
Nantahala Capital Management LLC Fulcrum Therapeutics Inc [2024-11-14] 0.0
BlackRock Inc Fulcrum Therapeutics Inc [2024-11-08] 9.1
BlackRock Inc Fulcrum Therapeutics Inc [2024-10-21] 9.1
TCG Crossover GP II LLC Fulcrum Therapeutics Inc [2024-09-20] 0.4
Adage Capital Partners GP LLC Fulcrum Therapeutics Inc [2023-03-06] 5.63
RA Capital Management LP Fulcrum Therapeutics Inc [2022-08-26] 13.45
Point72 Asset Management LP Fulcrum Therapeutics Inc [2022-06-22] 4.3
Adage Capital Partners GP LLC Fulcrum Therapeutics Inc [2022-03-10] 5.29
Cowen Financial Products LLC Fulcrum Therapeutics Inc [2022-03-09] 5.16
BlackRock Inc Fulcrum Therapeutics Inc [2022-02-04] 5.4
Suvretta Capital Management LLC Fulcrum Therapeutics Inc [2021-08-10] 5.5
RTW Investments LP Fulcrum Therapeutics Inc [2020-11-13] 7.55
Point72 Asset Management LP Fulcrum Therapeutics Inc [2020-09-18] 5.0
Casdin Capital LLC Fulcrum Therapeutics Inc [2020-02-20] 5.3
GlaxoSmithKline PLC Fulcrum Therapeutics Inc [2020-02-14] 7.7
FMR LLC Fulcrum Therapeutics Inc [2020-02-07] 0.0
Third Rock Ventures IV LP Fulcrum Therapeutics Inc [2020-02-05] 10.0
Third Rock Ventures III LP Fulcrum Therapeutics Inc [2020-02-05] 25.5
Sanofi Fulcrum Therapeutics Inc [2019-07-29] 2.4
Foresite Capital Fund IV LP Fulcrum Therapeutics Inc [2019-07-29] 7.2
Form 3/4/5 Filer 2011 - 2025
King Rachel K.
Fulcrum Therapeutics, Inc.
Ezekowitz Alan
Gould Robert J
Banks Sonja
Hill Colin
Haviland Kate
Dorton Katina
Geraghty James A
Tourangeau Greg
Oltmans Curtis Gale
Sapir Alex
Musso Alan A
RA Capital Management LP
Kolchinsky Peter
RA Capital Healthcare Fund LP
Shah Rajeev M.
Collins James J.
Horn Patrick Taylor
Hayes Melvin H. III
Rajavelu Esther
Third Rock Ventures III, L.P.
Third Rock Ventures GP III, L.P.
TRV GP III LLC
Tepper Robert I
Arroyo Santiago
Dunn Judith
Morabito Christopher
Stuart Bryan
Thomson Peter G.
Starr Kevin P
Levin Mark J
Moxham Christopher
Wallace Owen B.
Cadavid Diego
GSK plc
Sanofi
Section 32 Fund 2, LP
Maris William J
Section 32 GP 2, LLC
6 Dimensions Capital, L.P.
Casdin Partners Master Fund, L.P.
Casdin Partners GP, LLC
Casdin Capital, LLC
Casdin Eli
TRV GP IV LLC
Third Rock Ventures GP IV, L.P.
Third Rock Ventures IV, L.P.
Form 13F Holdings
Firm Period DFND Voting Shares
RA Capital Management LP [2025-06-30] SOLE 10,229,099 10,229,099
TCG Crossover Management LLC [2025-06-30] SOLE 5,250,000 5,250,000
Suvretta Capital Management LLC [2025-06-30] SOLE 5,082,900 5,082,900
Adage Capital Partners GP LLC [2025-06-30] SOLE 4,589,000 4,589,000
BlackRock, Inc. [2025-06-30] SOLE 4,206,333 4,379,023
Nantahala Capital Management LLC [2025-06-30] SOLE 4,288,299 4,288,299
Vanguard Group Inc [2025-06-30] SOLE 0 3,094,143
Balyasny Asset Management LP [2025-06-30] SOLE 1,338,214 1,338,214
Dimensional Fund Advisors LP [2025-06-30] SOLE 1,183,657 1,252,487
State Street Corp [2025-06-30] DFND 1,137,885 1,218,366
Geode Capital Management LLC [2025-06-30] DFND 1,193,138 1,193,138
D. E. Shaw & Co., Inc. [2025-06-30] DFND 1,148,411 1,176,711
Goldman Sachs Group Inc [2025-06-30] DFND 1,143,496 1,143,536
Ikarian Capital LLC [2025-06-30] SOLE 962,521 962,521
Woodline Partners LP [2025-06-30] SOLE 897,617 897,617
Northern Trust Corp [2025-06-30] DFND 603,456 603,456
Point72 Asset Management LP [2025-06-30] DFND 0 498,219
Invesco Ltd. [2025-06-30] DFND 0 470,333
Exome Asset Management LLC [2025-06-30] SOLE 444,949 444,949
Charles Schwab Investment Management Inc [2025-06-30] SOLE 387,782 387,782
Connor Clark & Lunn Investment Management Ltd [2025-06-30] SOLE 342,547 342,547
Boothbay Fund Management LLC [2025-06-30] OTR 0 332,278
Morgan Stanley [2025-06-30] DFND 285,545 314,410
Deutsche Bank AG [2025-06-30] DFND 120 279,251
Susquehanna International Group LLP [2025-06-30] OTR 99,490 250,190
Schonfeld Strategic Advisors LLC [2025-06-30] SOLE 204,400 204,400
Catalio Capital Management LP [2025-06-30] SOLE 188,304 188,304
Citadel Advisors LLC [2025-06-30] DFND 185,534 185,534
Prelude Capital Management LLC [2025-06-30] OTR 0 143,129
Bank of New York Mellon Corp [2025-06-30] DFND 122,122 137,000
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com